Cargando…
The Potassium Channel KCa3.1 Represents a Valid Pharmacological Target for Astrogliosis-Induced Neuronal Impairment in a Mouse Model of Alzheimer’s Disease
Alzheimer’s disease (AD) is a neurodegenerative disorder characterized by progressive decline of cognitive function. Astrogliosis plays a critical role in AD by instigating neuroinflammation, which leads ultimately to cognition decline. We previously showed that the intermediate-conductance Ca(2+)-a...
Autores principales: | Wei, Tianjiao, Yi, Mengni, Gu, Wen, Hou, Lina, Lu, Qin, Yu, Zhihua, Chen, Hongzhuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5214707/ https://www.ncbi.nlm.nih.gov/pubmed/28105015 http://dx.doi.org/10.3389/fphar.2016.00528 |
Ejemplares similares
-
The potassium channel KCa3.1 constitutes a pharmacological target for astrogliosis associated with ischemia stroke
por: Yi, Mengni, et al.
Publicado: (2017) -
KCa3.1 Inhibition Switches the Astrocyte Phenotype during Astrogliosis Associated with Ischemic Stroke Via Endoplasmic Reticulum Stress and MAPK Signaling Pathways
por: Yu, Zhihua, et al.
Publicado: (2017) -
Ca(2+)-dependent endoplasmic reticulum stress correlation with astrogliosis involves upregulation of KCa3.1 and inhibition of AKT/mTOR signaling
por: Yu, Zhihua, et al.
Publicado: (2018) -
Functional Cooperation between KCa3.1 and TRPV4 Channels in Bronchial Smooth Muscle Cell Proliferation Associated with Chronic Asthma
por: Yu, Zhihua, et al.
Publicado: (2017) -
The potassium channel KCa3.1 represents a valid pharmacological target for microgliosis-induced neuronal impairment in a mouse model of Parkinson’s disease
por: Lu, Jia, et al.
Publicado: (2019)